#2148 on the rich list of 14,644 insiders
Paul R. Edick
See Remarks at Xeris Biopharma Holdings. Based in Chicago, Illinois.
$63.5M
in disclosed stock, −$1.4M (−2.18%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 2148th of 14,644
- Companies held
- 1
- Largest holding
- XERS, 100.0% of total
- Latest SEC filing
- Jan 31, 2024
What the $63.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Xeris Biopharma Holdings XERS Common Stock | Directly | 3,788,064 | $16.62 | $63.0M | 99.1% | Form 4, Jan 31, 2024 |
| Xeris Biopharma Holdings XERS Common Stock | By: Paul R. Edick 2008 Revocable Trust u/d/t dated 6/25/2018 | 33,430 | $16.62 | $556K | 0.9% | Form 4, Jan 31, 2024 |
Share counts are the amounts Paul R. Edick reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 2145 | Robert Gries Jr. Director, Slide Insurance Holdings. Tampa, FL | $63.6M |
| 2146 | Thomas S. Bremner Director, BillionToOne. Chicago, IL | $63.5M |
| 2147 | Marshall Mohr Executive VP Global Business S, Intuitive Surgical. Pleasanton, CA | $63.5M |
| 2148 | Paul R. Edick See Remarks, Xeris Biopharma Holdings. Chicago, IL | $63.5M |
| 2149 | Lior Susan Director, Cerebras Systems. Sunnyvale, CA | $63.5M |
| 2150 | Matthew Ohayer 10% owner, Vital Farms. Austin, TX | $63.5M |
| 2151 | Hans C. Helmerich Director, Helmerich & Payne. Tulsa, OK | $63.3M |
Other Xeris Biopharma Holdings insiders
All XERS insiders- John Patrick Shannon Jr.$48.2MSee Remarks. #2611 overall
- Kevin McCulloch$26.3MSee Remarks. #4200 overall
- Steven Pieper$22.4MSee Remarks. #4763 overall
- Beth Hecht$18.1MSee Remarks. #5610 overall
- Steven Prestrelski$12.0MChief Scientific Officer. #7674 overall
- John Johnson$11.8MDirector. #7243 overall
Questions
How much stock does Paul R. Edick own?
Paul R. Edick holds $63,513,230 in listed stock based on SEC filings and current prices, mostly Xeris Biopharma Holdings (XERS). That ranks 2148th on the Stock Rich List.
Is this Paul R. Edick's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.